Tue, Oct 21, 2014, 4:55 AM EDT - U.S. Markets open in 4 hrs 35 mins

Recent

% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • jd9919 jd9919 Feb 27, 2012 9:02 PM Flag

    Synergy with HSP90 inhibition

    Interesting (albeit preliminary) ...

    News Breaks
    February 27, 2012
    08:03 EDT OGXI theflyonthewall.com: OncoGenex reports positive data for compound OGX-427
    OncoGenex announced that preclinical data utilizing their pipeline compound OGX-427 was presented at the 27th Annual EAU Congress.This preclinical study, along with previously reported preclinical data, further demonstrated the potential of OGX-427 to augment anti-cancer therapies and delay tumor progression. The study showed that when Hsp27 was decreased via OGX-427 treatment, the effect of the Hsp90 inhibitors was enhanced and tumor cell death was observed. The authors concluded OGX-427 in combination with Hsp90 inhibitors potentiated the effects of Hsp90, delayed tumor growth and prolonged survival in murine prostate cancer models. :theflyonthewall.com

    http://www.theflyonthewall.com/permalinks/entry.php/OGXIid1586694/OGXI-OncoGenex-reports-positive-data-for-compound-OGX

    Switching subjects, why-oh-why did I ever buy DNDN at $30???!!! (just venting)

 
OGXI
2.17-0.03(-1.36%)Oct 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TOTAL S.A.
NYSEMon, Oct 20, 2014 4:03 PM EDT
NCR Corp.
NYSEMon, Oct 20, 2014 4:02 PM EDT